Programmatic review services for the fiscal year 2020 amyotrophic lateral sclerosis research program for the congressionally directed medical research programs.
Ended Awarded Last action
- Contract number
- W81XWH20F0199
- Awardee
-
Leidos, Inc. UEI QLNMVC12KWY3 Part of Leidos Holdings, Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $405,475
Award facts
- Opportunity
-
- W81XWH17R0036 Solicitation number
- Meeting, Scientific and Administrative Support Services (MSASS), Request for Proposal (RFP) Award Notice · Posted Apr 12, 2017
- Meeting, Scientific and Administrative Support Services Award Notice · Posted Mar 22, 2017
- Contract value 78% obligated
- $520,785.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Two Step
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$21,702 | |
| Funding Only Action | -$1,856 | |
| Funding Only Action | -$32,252 | |
| Funding Only Action | $85,861 | |
| Funding Only Action | -$39,000 | |
| Exercise an Option | $87,878 | |
| Funding Only Action | $0 | |
| Change Order | -$17,778 | |
| Exercise an Option | $173,214 | |
| Funding Only Action | $101,111 | |
| Original award | $70,000 |
Show all 11
About this award
The Defense Health Agency issued a delivery order to Leidos, Inc. on May 1, 2020, with a ceiling value of $520,785.96 for programmatic review services supporting the Fiscal Year 2020 Amyotrophic Lateral Sclerosis Research Program under the Congressionally Directed Medical Research Programs.
Place of performance is Frederick, MD 21702. The order is priced cost plus fixed fee and has an ultimate completion date of April 30, 2023. Scope includes vision setting, pre-application screening, and general program support services for the ALS research program.
Quick answers
Who was awarded contract W81XWH20F0199?
W81XWH20F0199 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on May 1, 2020.
How much is contract W81XWH20F0199 worth?
The government has obligated $405,475 on W81XWH20F0199. Its current value, with exercised options, is $520,786.
Is contract W81XWH20F0199 an order under another contract?
Yes. W81XWH20F0199 is a delivery order under W81XWH17D0025, an indefinite delivery contract.
Was contract W81XWH20F0199 competed?
The extent of competition for W81XWH20F0199 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award